Meeting Report on FASEB Protein Arginine Methylation: Mechanism to Therapeutics - PubMed
5 hours ago
- #Protein Arginine Methylation
- #PRMTs
- #Therapeutic Strategies
- Inaugural FASEB conference on protein arginine methylation held in Tsukuba, Japan, January 5-8, 2026.
- Conference focused on protein arginine methyltransferases (PRMTs) and their methylarginine products, including MMA, ADMA, and SDMA.
- Arginine methylation regulates RNA metabolism, chromatin function, and cellular stress responses.
- Presentations covered PRMT roles in RNA processing, gene expression, genome stability, and cellular metabolism.
- New methylarginine reader proteins were identified.
- Research expanded into immune, antiviral pathways, and neuroscience.
- Advances in chemical probes, degraders, and selective inhibitors are aiding PRMT study and therapeutic development.